Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Successful preclinical data for ImmCelz as treatment of stroke

Jan. 13, 2021

Alzheimer's disease subtypes may explain, improve clinical results

Jan. 13, 2021

Amnion secretome neuroprotection takes all parts

Jan. 13, 2021

mRNA vaccine can tamp down immunity, too

Jan. 13, 2021

New heterocyclic ring systems as a novel class of brain-penetrating V1A antagonists

Jan. 12, 2021

Dyne reports preclinical data from DM1 program

Jan. 12, 2021

Phase II TRAILBLAZER-ALZ trial of donanemab in Alzheimer's meets primary endpoint

Jan. 11, 2021

Celon reports topline phase II data on Falkieri in bipolar depression

Jan. 11, 2021

Discovery of non-sugar-derived OGA inhibitors for neurodegenerative disorders

Jan. 11, 2021

Calithera Biosciences presents CD73 inhibitors

Jan. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...